Physician profile
Amber Stepp
NPI 1295048973
$4,104.47
in general payments reported to CMS, 2019-2025
7 companies · $564 in 2025
The $564 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $517 · 2022: $754 · 2023: $1,715 · 2024: $554 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,517.99 | 2022-2025 | Barostim Neo System |
| Abbott Laboratories | $1,366.66 | 2021-2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $685.81 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $408.27 | 2022 | |
| Alnylam Pharmaceuticals INC. | $60.65 | 2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $34.26 | 2022-2025 | Optimizer |
| Novartis Pharmaceuticals Corporation | $30.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Stepp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.